Ochre Bio

Biopharma, Biotechnology, Health Care, Therapeutics
Founded in 9/1/19
Oxford, Oxfordshire, United Kingdom
http://www.ochre-bio.com
For Profit

About Ochre Bio

Ochre Bio develops genomic medicines to rejuvenate donors' livers before transplant, so that everyone who needs a new liver gets one. They use genomics to find and shut down over-active genes driving disease and then go directly to testing therapies in discarded donor livers that keep alive outside of the body. Ochre Bio is within the heart of Oxford’s biotech innovation hub. Their scientific roots can be traced back to over 15 years leading liver genomics research and experience in bringing advanced therapies to market.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: 5278
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 39750000 USD
  • Last Funding: 30000000 USD (Series A)
  • Funding Status: Early Stage Venture

Technology Stack

Ochre Bio actively uses None products in their tech stack.

Market Presence

Industries: Biopharma, Biotechnology, Health Care, Therapeutics

Headquarters: Oxford, Oxfordshire, United Kingdom

Leadership

Employees